☆ 4.3 Article

PLAGL2 increases adriamycin resistance and EMT in breast cancer cells by activating the Wnt pathway

GENES & GENOMICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Tweaking EMT and MDR dynamics to constrain triple-negative breast cancer invasiveness by EGFR and Wnt/β-catenin signaling regulation

Rajib Shome et al.

Summary: The study revealed that targeting both the EGFR and Wnt/beta-catenin signaling pathways in TNBC cells can promote the transition from mesenchymal to epithelial state, overcoming EMT and MDR and offering new avenues for treating the disease.

CELLULAR ONCOLOGY (2021)

添加到收藏夹

Review Oncology

Triple-negative breast cancer: understanding Wnt signaling in drug resistance

Parnaz Merikhian et al.

Summary: Triple-negative breast cancer presents challenges in treatment strategies due to its complexity and heterogeneity, with research showing the pivotal role of Wnt/beta-catenin signaling in resistance development.

CANCER CELL INTERNATIONAL (2021)

添加到收藏夹

Review Medicine, Research & Experimental

A comprehensive review on time-tested anticancer drug doxorubicin

Sruthi Sritharan et al.

Summary: Doxorubicin is a widely used chemotherapeutic drug for cancer treatment, inducing cell death through various mechanisms and aiding in immune clearance of tumor cells, but its applicability is limited by the development of chemoresistance and cardiotoxicity. Various formulations and co-treatments are essential in reducing toxicity and combating resistance. Further research into the molecular mechanisms of chemoresistance development is crucial for improving patient survivability and preventing cancer relapse.

LIFE SCIENCES (2021)

添加到收藏夹

Article Oncology

Selenium sulfide disrupts the PLAGL2/C-MET/STAT3-induced resistance against mitochondrial apoptosis in hepatocellular carcinoma

Tianfeng Yang et al.

Summary: The study revealed the association of PLAGL2 overexpression with apoptosis resistance in HCC, and demonstrated that SeS2 can induce apoptosis in HCC cells by suppressing multiple signaling pathways. The potential of using SeS2 as a PLAGL2 inhibitor in patients with HCC was highlighted.

CLINICAL AND TRANSLATIONAL MEDICINE (2021)

添加到收藏夹

Article Medicine, Research & Experimental

PLAGL2 promotes the proliferation and migration of gastric cancer cells via USP37-mediated deubiquitination of Snail1

Liang Wu et al.

Summary: Overall, PLAGL2 promotes the proliferation and migration of GC cells through USP37-mediated deubiquitination of Snail1 protein. This work provided potential therapeutic targets for GC treatment.

THERANOSTICS (2021)

添加到收藏夹

Article Oncology

PLAGL2 promotes epithelial-mesenchymal transition and mediates colorectal cancer metastasis via β-catenin-dependent regulation of ZEB1

Liang Wu et al.

BRITISH JOURNAL OF CANCER (2020)

添加到收藏夹

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

添加到收藏夹

Review Oncology

Advancing Cancer Research and Medicine with Single-Cell Genomics

Bora Lim et al.

CANCER CELL (2020)

添加到收藏夹

Review Oncology

Overcoming Endocrine Resistance in Breast Cancer

Ariella B. Hanker et al.

CANCER CELL (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities

Xiufang Xu et al.

MOLECULAR CANCER (2020)

添加到收藏夹

Article Oncology

APC loss affects DNA damage repair causing doxorubicin resistance in breast cancer cells

Casey D. Stefanski et al.

NEOPLASIA (2019)

添加到收藏夹

Review Biotechnology & Applied Microbiology

Aptamer selection and applications for breast cancer diagnostics and therapy

Mei Liu et al.

JOURNAL OF NANOBIOTECHNOLOGY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer

Xiaofeng Zheng et al.

NATURE (2015)

添加到收藏夹

Article Multidisciplinary Sciences

Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance

Kari R. Fischer et al.

NATURE (2015)

添加到收藏夹

Review Oncology

Precision medicine for metastatic breast cancer-limitations and solutions

Monica Arnedos et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2015)

添加到收藏夹

Review Oncology

Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance

Paraskevi Mallini et al.

CANCER TREATMENT REVIEWS (2014)

添加到收藏夹

Article Oncology

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

John R. Mackey et al.

LANCET ONCOLOGY (2013)

添加到收藏夹

Article Oncology

Expression of Wnt3 Activates Wnt/β-Catenin Pathway and Promotes EMT-like Phenotype in Trastuzumab-Resistant HER2-Overexpressing Breast Cancer Cells

Yanyuan Wu et al.

MOLECULAR CANCER RESEARCH (2012)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.